Literature DB >> 2986544

In vitro activities of bismuth salts against rotaviruses and other enteric viruses.

R L Ward, D S Sander, D R Knowlton.   

Abstract

Bismuth salts inhibited plaque formation of all enteric viruses tested, which included four strains of rotavirus and one strain each of echovirus, reovirus, and poliovirus. The compounds had no direct virucidal effect at concentrations ranging from 0.025 to 2.5 mg/ml, and the inhibitory effects were observed only at concentrations slightly below those that caused extensive cytotoxicity. Plaque inhibition appeared to result from interference with host cell functions, with secondary inhibition of virus production.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986544      PMCID: PMC176266          DOI: 10.1128/AAC.27.3.306

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Inactivation of poliovirus in digested sludge.

Authors:  R L Ward; C S Ashley
Journal:  Appl Environ Microbiol       Date:  1976-06       Impact factor: 4.792

2.  Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university.

Authors:  H L DuPont; P Sullivan; L K Pickering; G Haynes; P B Ackerman
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

3.  Efficiency of human rotavirus propagation in cell culture.

Authors:  R L Ward; D R Knowlton; M J Pierce
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

4.  Bismuth subsalicylate therapy of viral gastroenteritis.

Authors:  M C Steinhoff; R G Douglas; H B Greenberg; D R Callahan
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

5.  Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.

Authors:  C D Ericsson; D G Evans; H L DuPont; D J Evans; L K Pickering
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

6.  Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.

Authors:  D Y Graham; M K Estes; L O Gentry
Journal:  Gastroenterology       Date:  1983-11       Impact factor: 22.682

  6 in total
  2 in total

1.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

2.  Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.

Authors:  Adam M Pitz; Geun Woo Park; David Lee; Ying L Boissy; Jan Vinjé
Journal:  Gut Microbes       Date:  2015
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.